Status:
COMPLETED
Penile Length Restoration in Men With Diabetes Mellitus, Type II
Lead Sponsor:
Mayo Clinic
Conditions:
Diabetes Mellitus, Type 2
Penile Diseases
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The objective of the current study is to evaluate the efficacy of a novel penile traction device in restoring lost penile length in men with type 2 diabetes.
Detailed Description
Men with diabetes mellitus experience sexual dysfunctions at an earlier age and higher rate compared to men without diabetes. One of these sexual dysfunctions includes diminished penile length. It is ...
Eligibility Criteria
Inclusion
- \- Men with Diabetes Mellitus, Type II
Exclusion
- Any evidence of end-organ failure attributed to DM (assessed based on medical history / patient history alone)
- Loss of fingers / toes.
- CKD Stage IV or greater.
- Retinopathy
- Myocardial infarction.
- Cerebrovascular accident.
- Indwelling penile prosthesis or prior history of penile prosthesis.
- Peyronie's disease at baseline.
Key Trial Info
Start Date :
November 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 18 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03756688
Start Date
November 7 2018
End Date
March 18 2021
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905